SAN DIEGO, May 3, 2011 /PRNewswire/ -- Althea Technologies, Inc. announced today that they have entered into a commercial supply agreement with Biotest Pharmaceuticals Corporation. Under the terms of the agreement, Althea will fill commercial drug products to supply the U.S. market. The products will be filled in Althea's new commercial manufacturing facility in San Diego.
"We are very pleased to be selected by Biotest as their strategic partner and commercial filler," stated Rick Hancock, President, Althea Technologies. "We are looking forward to supporting Biotest as their commercial manufacturing partner."
About Althea Technologies, Inc.
Althea Technologies is a fully integrated, contract development and manufacturing organization that provides services for plasmid DNA, recombinant proteins, and sterile products. Located in San Diego, CA, Althea offers cell banking, process development, cGMP protein & plasmid production, analytical development, formulation and lyophilization development, and aseptic filling in vials & prefilled syringes for clinical development and commercialization. Althea's formulation technology platform employs crystalomics that can be applied to a variety of peptides and proteins for high concentration or sustained release formulations. For more information, visit www.altheatech.com.